Cannabinoid exposure during pregnancy and its impact on immune function

Area of Science:

• Immunology
• Developmental Biology
• Pharmacology

Background:

• Cannabinoids, including synthetic forms, are widely abused drugs.
• Exposure during pregnancy is a significant concern as compounds cross the placental barrier.
• Cannabinoids interact with CB1 and CB2 receptors, impacting neurological and immune functions.

Purpose of the Study:

• To review the immunomodulatory effects of cannabinoid exposure.
• To examine the potential consequences for fetal immune development.
• To highlight the role of epigenetic mechanisms in long-term impacts.

Main Methods:

• Literature review of studies on cannabinoid exposure and immune function.
• Analysis of research on placental transfer and fetal exposure.
• Examination of evidence for epigenetic modifications.

Main Results:

• Cannabinoids induce significant immunomodulation, altering cytokine profiles and inducing cell death/suppressor cells.
• Maternal exposure can lead to fetal immune system dysregulation, affecting both innate and adaptive immunity.
• Epigenetic mechanisms are implicated in the lasting effects of in utero cannabinoid exposure.

Conclusions:

• Maternal cannabinoid use poses risks to fetal immune development, potentially compromising long-term health.
• Offspring may face increased vulnerability to infections and cancers due to altered immune defenses.
• Further research into epigenetic effects is crucial for understanding and mitigating these risks.